{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-003890","form_type":"8-K","ticker":"SNWV","cik":"0001417663","company_name":"SANUWAVE Health, Inc.","filed_at":"2024-01-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.122332+00:00","generated_at":"2026-06-06T18:11:47.205864+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Sanuwave Health issues $4.6M convertible notes & warrants to existing note holders; no cash proceeds","bullets":["Issued $4.6M principal amount of Future Advance Convertible Promissory Notes at 15% interest, convertible at $0.04/share, to prior ABL note holders.","Issued Warrants to purchase 113.9M shares at $0.067 and 113.9M shares at $0.04, exercisable for 5 years.","No cash proceeds; notes and warrants exchanged for prior $4.6M ABL notes issued July 2023 at 33% OID.","Entered subordination agreement with NH Expansion Credit Fund Holdings LP; North Haven holds senior rights.","Waiver letter postpones obligations for reverse stock split, share reserve, and registration statement filing through Dec 31, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-003890","json":"https://secwatch.observer/filing/0001140361-24-003890.json","markdown":"https://secwatch.observer/filing/0001140361-24-003890.md","text":"https://secwatch.observer/filing/0001140361-24-003890.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417663/000114036124003890/0001140361-24-003890-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417663/000114036124003890/ny20018318x4_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T18:11:47.205864+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"09ee2e727e332922188b893ceb5d00ea62745b6f","claim":"SANUWAVE Health, Inc. entered into Securities Purchase Agreement with certain accredited investors valued at aggregate principal amount of approximately $4.6 million (effective 2024-01-21).","evidence_excerpt":"On January 21, 2024, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”), with the Purchasers for the sale by the Company in a private placement (the “January Private Placement”) of (i) the Company’s Future Advance Convertible Promissory Notes in an aggregate principal amount of approximately $4.6 million","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417663/000114036124003890/0001140361-24-003890-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain accredited investors"},{"label":"Value","value":"aggregate principal amount of approximately $4.6 million"},{"label":"Effective","value":"2024-01-21"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}